ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Lung Transplant

March 24, 2014
On March 20, 2014, a panel of the FDA gave unanimous approval for use of an ex-vivo perfusion system for improving the quality of explanted lungs prior to transplantation.  If this recommendation is followed by the FDA, such devices could be used clinically under IRB protocols.
March 22, 2014
On March 20, 2014, a panel of the FDA gave unanimous approval for use of an ex-vivo perfusion system for improving the quality of explanted lungs prior to transplantation. If this recommendation is followed by the FDA, such devices could be used clinically under IRB protocols.
January 23, 2014
A new endoscopic standardized grading system for macroscopic central airway complications following lung transplantation is suggested by a group of French bronchoscopy experts. It considers macroscopic appearance, diameters and sutures of the bronchial anastomoses.
August 12, 2012
Prof. John Dark performed Europe's first double lung transplant. In this interview he discusses his criteria for acceptance of a donor lung, non-heart beating donation, ex vivo lung perfusion, his techniques for implantation and his vision of the future of lung transplantation.
July 19, 2012
The Novalung Interventional Lung Assist (iLA) device is a membrane ventilator that allows for oxygen and carbon dioxide gas exchange to occur by simple diffusion.
January 17, 2011
In 1932, the radiologist Henry Pancoast first described a superior pulmonary sulcus tumor (SST) as a carcinoma (of uncertain origin) developing in the apex of the chest.
August 30, 2010
Pericardial cysts are an uncommon benign congenital anomaly in the middle mediastinum.  They represent 6% of mediastinal masses, and 33% of mediastinal cysts.  Other cysts in the mediastinum are bronchogenic – 34%, enteric – 12%, thymic and others – 21%.
August 30, 2010
Hemodynamically stable patients with an undiagnosed pericardial effusion are well suited for a thoracoscopic window. When pericardial, pleural, or pulmonary pathology co-exist and require diagnosis or therapy, a thoracoscopic approach is ideal.

Pages